USPTO 2015–2025 USPTO PatentsView US Corporation

Conagen Inc.

USPTO PatentsView assignee record - 58 granted patents across 16 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.6

Avg claims per patent

+42%

5-year filing velocity

The verdict

Conagen holds 58 US patents across 16 technology areas, rank #5,829 of 50,000 tracked assignees.

#5,829
of 50,000 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 14.6
avg claims per patent: +42%
filing velocity, last 5 yrs

Portfolio overview

Conagen Inc. has been granted 58 US utility patents between 2016 and 2025, placing Conagen Inc. at rank #5,829 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Conagen Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Conagen sits between Collateral Opportunities, Llc (58 patents, rank #5,825) and Duquesne University Of The Holy Spirit (58 patents, rank #5,833) - the closest US assignees by grant volume. The composite Innovation Score of 40.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 34 grants, compared with 24 in the 2015–2019 window, a +42% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Conagen Inc.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Conagen Inc. against peers pursuing similar technology classes.

Collateral Opport…

58
Carlisle Fluid

58
Carlson Pet Produ…

58
Compagnie Gervais…

58
Contec

58
Dfine

58
Dongbu Hitek

58
Duquesne Universi…

58
Conagen ◀

58

What this shows Conagen holds 58 patents at rank #5,829, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Conagen

By rank, the assignees closest to #5,829 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Conagen's primary technology class.

Conagen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Conagen Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	3.4%
2017	5	8.6%
2018	10	17.2%
2019	7	12.1%
2020	15	25.9%
2021	5	8.6%
2022	7	12.1%
2023	2	3.4%
2024	4	6.9%
2025	1	1.7%

Which technologies does Conagen Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 55

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 53

C12Y - ENZYMES 48

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 35

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 35

C07K - PEPTIDES 33

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 29

A23G - COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF 6

A21D - TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS 6

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 5

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 3

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3

A23K - FODDER 3

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 2

C07D - HETEROCYCLIC COMPOUNDS 2

Top 15 of 16 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#5,829

Across all tracked assignees

Innovation Score

40.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Conagen Inc. hold?

Conagen Inc. holds 58 US granted patents filed between 2016 and 2025, spanning 16 technology areas.

What is Conagen Inc.'s Innovation Score?

Conagen Inc. has an Innovation Score of 40.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Conagen Inc. focus on?

Conagen Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 55 patents. The company has filed patents in 16 CPC subclasses total.

Is Conagen Inc.'s patent filing rate increasing or decreasing?

Conagen Inc.'s recent filing velocity is +42% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Conagen Inc.'s patents?

Conagen Inc.'s patents average 14.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Conagen Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Conagen's 58 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Conagen ranks #5,829 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.